glp-1 drugs and high blood pressure Agonists Pressure: A Review of the Evidence | Current Hypertension Reports Obesity and Hypertension: Can GLP-1

Oxidative stress in Parkinson's disease

Cardiovascular Risks of GLP-1 Medications GLP-1 receptor agonists, like semaglutide, liraglutide, dulaglutide, and tirzepatide, are widely used for managing type 2 diabetes and obesity

We therefore suggest future studies to more thoroughly report maternal and treatment characteristics including trimester of exposure

In some cases, GLP-1 therapy may indirectly support arthritis management by improving weight, cardiovascular risk, and overall quality of life

Due to their preclinical testing and lack of comparison with other dual receptor agonists such as tirzepatide, further studies are needed to determine whether the effects of these unimolecular compounds are superior to those of clinically tested drugs